Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2016 16:15 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics to Present at the 28th Annual ROTH Conference

PRINCETON, N.J., March 03, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
February 18, 2016 17:20 ET | Source: EWTN Global Catholic Network

Appeals Court Rules Against EWTN in HHS Mandate Case

Irondale, AL, Feb. 18, 2016 (GLOBE NEWSWIRE) -- This afternoon, the 11th Circuit U.S. Court of Appeals in Atlanta ruled against EWTN Global Catholic Network in its long-running battle against...
February 04, 2016 16:10 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters

PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
January 22, 2016 09:16 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock

PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
January 15, 2016 16:31 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics to Present at Noble Financial Capital Markets’ Twelfth Annual Equity Conference

PRINCETON, N.J., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
December 01, 2015 07:45 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey’s Technology Business Tax Certificate Transfer Program

PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription...
November 09, 2015 16:10 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Reports Third Quarter Financial Results

PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
November 04, 2015 09:15 ET | Source: WomanCare Global

The Population Council and WomanCare Global Announce Worldwide License Agreement to Advance Women's Access to Innovative Contraceptive Ring

NEW YORK and SAN DIEGO, Nov. 4, 2015 (GLOBE NEWSWIRE) -- In a major step forward for women's health, the Population Council and WomanCare Global (WCG) today announced an exclusive worldwide licensing...
October 19, 2015 16:08 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial

PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
September 03, 2015 07:45 ET | Source: Agile Therapeutics, Inc.

Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference

PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...